News & Views03 Feb 2025Nature Medicine Volume: 31, P: 382-383 Inhibition of ERα signaling induces lineage plasticity in vivo Mutations inESR1, which encodes estrogen receptor-α (ERα), drive resistance to approved endocrine therapies in breast cancer. We studied the molecular response to the...
Latest News Camizestrant Plus CDK4/6 Inhibitors Shows PFS Benefit in HR+/HER2- Breast Cancer By Jordyn Sava February 27th 2025 Camizestrant combined with CDK4/6 inhibitors improved progression-free survival in HR+/HER2- advanced breast cancer with ESR1 mutations in the SERENA-6 trial. FDA ...
Follow the latest Breast Cancer news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to Breast Cancer notifications.
Follow the latest Breast Cancer news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to Breast Cancer notifications.
CBS News medical contributor Dr. Céline Gounder explains why experts hope more aggressive screening guidelines will help address some concerning breast cancer trends. May 1, 2024 Show More Trump on peace negotiations: "Maybe Russia will give up a lot. Maybe they won't." ...
NewsTheralink Begins Testing New Biomarker Assay for Breast Cancer Tumors NewsUS Study Enrolling Women to Help Determine Best Screening Practices NewsNonprofit Highlights Importance of Global Teamwork for World Cancer Day NewsEnhertu Approved in EU for Inoperable, Advanced Breast Cancer ...
Breast Cancer: Fear of Recurrence Can Haunt Women for Years HealthDayFeb. 10, 2025 Super Bowl Commercials Rely on Comedy and Nostalgia to Avoid Potential Missteps The Philadelphia Eagles dominated the Kansas City Chiefs on the field in this year’s Super Bowl, while laughter dominated the commer...
Latest News FDA Expands PATHWAY HER2 (4B5) Test to Include HER2-Ultralow Status By Jordyn Sava February 6th 2025 The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its prior HER2-low indication. FDA Considers BLA for ...
The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and ...
Find the latest Breast Cancer news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.